Mehadrin Ltd. (MEDN.TA)
ILA 23820.0
(0.04%)
ILA 23820.0
(0.04%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 735.07 Million ILS | 4.77% |
| 2022 | 701.6 Million ILS | 5.94% |
| 2021 | 662.26 Million ILS | -0.29% |
| 2020 | 664.2 Million ILS | -17.31% |
| 2019 | 803.22 Million ILS | 5.48% |
| 2018 | 761.47 Million ILS | -5.44% |
| 2017 | 805.3 Million ILS | 1.64% |
| 2016 | 792.3 Million ILS | -1.31% |
| 2015 | 802.85 Million ILS | -0.34% |
| 2014 | 805.62 Million ILS | 4.38% |
| 2013 | 771.79 Million ILS | -3.24% |
| 2012 | 797.65 Million ILS | 3.48% |
| 2011 | 770.79 Million ILS | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 585.82 Million ILS | -19.96% |
| 2024 Q1 | 731.91 Million ILS | -0.43% |
| 2023 Q2 | 615.49 Million ILS | -18.09% |
| 2023 Q4 | 735.07 Million ILS | 12.84% |
| 2023 FY | 735.07 Million ILS | 4.77% |
| 2023 Q3 | 651.43 Million ILS | 5.84% |
| 2023 Q1 | 751.43 Million ILS | 7.1% |
| 2022 Q1 | 636.44 Million ILS | -3.9% |
| 2022 FY | 701.6 Million ILS | 5.94% |
| 2022 Q3 | 542.07 Million ILS | 1.1% |
| 2022 Q4 | 701.6 Million ILS | 29.43% |
| 2022 Q2 | 536.15 Million ILS | -15.76% |
| 2021 Q3 | 643.14 Million ILS | 7.84% |
| 2021 Q1 | 769.58 Million ILS | 15.87% |
| 2021 Q4 | 662.26 Million ILS | 2.97% |
| 2021 Q2 | 596.39 Million ILS | -22.51% |
| 2021 FY | 662.26 Million ILS | -0.29% |
| 2020 FY | 664.2 Million ILS | -17.31% |
| 2020 Q4 | 664.2 Million ILS | -2.41% |
| 2020 Q1 | 812.18 Million ILS | 1.12% |
| 2020 Q2 | 673.66 Million ILS | -17.05% |
| 2020 Q3 | 680.63 Million ILS | 1.03% |
| 2019 Q4 | 803.22 Million ILS | -2.2% |
| 2019 Q3 | 821.27 Million ILS | 4.55% |
| 2019 Q2 | 785.5 Million ILS | -20.19% |
| 2019 FY | 803.22 Million ILS | 5.48% |
| 2019 Q1 | 984.18 Million ILS | 29.25% |
| 2018 Q2 | 702.38 Million ILS | -24.48% |
| 2018 FY | 761.47 Million ILS | -5.44% |
| 2018 Q3 | 678.13 Million ILS | -3.45% |
| 2018 Q1 | 930.09 Million ILS | 15.5% |
| 2018 Q4 | 761.47 Million ILS | 12.29% |
| 2017 Q3 | 652.79 Million ILS | -13.12% |
| 2017 FY | 805.3 Million ILS | 1.64% |
| 2017 Q1 | 923.36 Million ILS | 16.54% |
| 2017 Q4 | 805.3 Million ILS | 23.36% |
| 2017 Q2 | 751.34 Million ILS | -18.63% |
| 2016 Q2 | 730.82 Million ILS | -15.07% |
| 2016 FY | 792.3 Million ILS | -1.31% |
| 2016 Q1 | 860.46 Million ILS | 7.18% |
| 2016 Q4 | 792.3 Million ILS | 10.59% |
| 2016 Q3 | 716.41 Million ILS | -1.97% |
| 2015 Q3 | 605.79 Million ILS | -12.8% |
| 2015 Q4 | 802.85 Million ILS | 32.53% |
| 2015 Q2 | 694.68 Million ILS | -14.44% |
| 2015 Q1 | 811.91 Million ILS | 0.78% |
| 2015 FY | 802.85 Million ILS | -0.34% |
| 2014 Q2 | 714.39 Million ILS | -20.43% |
| 2014 FY | 805.62 Million ILS | 4.38% |
| 2014 Q1 | 897.84 Million ILS | 16.33% |
| 2014 Q3 | 641.04 Million ILS | -10.27% |
| 2014 Q4 | 805.62 Million ILS | 25.67% |
| 2013 Q1 | 854 Million ILS | 7.06% |
| 2013 Q3 | 617.94 Million ILS | -1.44% |
| 2013 Q2 | 626.98 Million ILS | -26.58% |
| 2013 Q4 | 771.79 Million ILS | 24.9% |
| 2013 FY | 771.79 Million ILS | -3.24% |
| 2012 Q4 | 797.65 Million ILS | 0.0% |
| 2012 FY | 797.65 Million ILS | 3.48% |
| 2011 FY | 770.79 Million ILS | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|